USPSTF: Evidence Lacking for Screening Asymptomatic Patients for Skin Cancer
TUESDAY, April 18, 2023 (HealthDay News) -- The U.S. Preventive Services Task Force (USPSTF) concludes that the current evidence is insufficient for assessing the balance of benefits and harms of screening asymptomatic adults and adolescents for skin cancer. These findings form the basis of a final recommendation statement published in the April 18 issue of the Journal of the American Medical Association.
Nora B. Henrikson, Ph.D., M.P.H., from the Kaiser Permanente Washington Health Statement Research Institute in Seattle, and colleagues conducted a systematic review of the benefits and harms of screening for skin cancer. Data were included from 20 studies in 29 articles, with 6,053,411 asymptomatic individuals aged 15 years or older. The researchers found that based on direct evidence on screening effectiveness from three nonrandomized analyses, no melanoma mortality benefit was seen at the population level over four to 10 years of follow-up. Inconsistent evidence on the association between clinician skin examination and lesion thickness or stage at diagnosis was seen in six studies. Routine clinician skin examination was not associated with increased detection of skin cancer or precursor lesions or with stage at melanoma detection compared with usual care.
Based on these findings, the USPSTF concludes that the evidence is inadequate for assessing the balance of benefits and harms of visual skin examination to screen for skin cancer in asymptomatic adolescents and adults (I statement).
"We need more research on whether or not screening for skin cancer in people without symptoms is beneficial," a task force member said in a statement. "To help prevent skin cancer, people should minimize sun exposure, protect their skin when in the sun, and avoid tanning beds."
Final Recommendation Statement
Related Posts
Healthy Lifestyle Cuts Prostate Cancer Mortality Among High-Risk Men
FRIDAY, July 15, 2022 (HealthDay News) -- Adherence to a healthy lifestyle is...
Unos nuevos datos confirman que el refuerzo actualizado de Pfizer se dirige a las variantes ómicron
VIERNES, 14 de octubre de 2022 (HealthDay News) -- Los datos de un nuevo ensayo...
In National Survey, U.S. Ob-Gyns Say Care Has Worsened After Dobbs Decision
WEDNESDAY, June 21, 2023 (HealthDay News) -- The U.S. Supreme Court decision...
Poll: Inflation Has Many Americans Cutting Back on Health Care
MONDAY, Aug. 8, 2022 (HealthDay News) -- Inflation is putting Americans'...